Description
B7-33 research peptide
B7-33 is a single-chain peptide analogue derived from the B-chain of human relaxin-2. It was designed to activate the RXFP1 receptor with biased signalling.
Product details
| Compound | B7-33 |
|---|---|
| Class | Single-chain relaxin-2 analogue |
| Strength | 6mg; 12mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What B7-33 research has examined
- RXFP1 signalling: biased agonism toward pERK pathways.
- Fibrosis models: anti-fibrotic research in heart, lung and kidney.
- Analogue design: simplifying the two-chain relaxin structure.
Research interest does not establish a proven effect in humans.
Regulatory status
B7-33 is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Syn-Ake · HMG (Human Menopausal Gonadotropin) · LL-37 (CAP-18) · All unreconstituted peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.